Replimune Group, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ASND
|
Ascendis Pharma A/S | $142.68 | $7.77 B | -14.19 | 879 | $266.72 M |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.04 | $597.48 M | -6.84 | 51 | $0 |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $53.14 | $3.53 B | -11.86 | 290 | $4.01 M |
 GOSS
|
Gossamer Bio, Inc. | $1.07 | $124.06 M | -0.65 | 135 | $0 |
 KRON
|
Kronos Bio, Inc. | $0.97 | $44.62 M | -0.37 | 58 | $6.29 M |
 KROS
|
Keros Therapeutics, Inc. | $61.06 | $1.76 B | -9.45 | 149 | $151,000 |
 KURA
|
Kura Oncology, Inc. | $18.06 | $1.66 B | -10.03 | 142 | $0 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.24 | $19.53 M | -0.27 | 88 | $1.56 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $13.82 | $652.38 M | -6.03 | 28 | $0 |
 MRUS
|
Merus N.V. | $51.80 | $3.50 B | -19.38 | 172 | $43.95 M |
 NAMS
|
NewAmsterdam Pharma Company N.V. | $18.22 | $1.74 B | -7.15 | 57 | $12.76 M |
 NUVL
|
Nuvalent, Inc. | $105.09 | $5.11 B | -32.72 | 115 | $0 |
 NVCT
|
Nuvectis Pharma, Inc. | $6.10 | $116.38 M | -4.5 | 13 | $0 |
 PRTC
|
PureTech Health plc | $20.33 | $809.08 M | -12.47 | 90 | $3.33 M |
 PTGX
|
Protagonist Therapeutics, Inc. | $44.38 | $2.04 B | 13.7 | 125 | $60.00 M |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.82 | $1.66 B | -6.02 | 184 | $0 |
 UTHR
|
United Therapeutics Corporation | $355.67 | $12.20 B | 13.02 | 1168 | $2.33 B |
 VTYX
|
Ventyx Biosciences, Inc. | $2.12 | $229.83 M | -1.01 | 73 | $0 |